Found 234 Results
Page 8 of 12

Home


Enhancing Immune Function Without Needles Partnering with pharmaceutical companies to improve their injectable products Speak with an Expert Needle-free is Making an Impact on Healthcare Partner Benefits Improves vaccines and therapeutics Proven regulatory pathway No drug reformulation Same fill/finish manufacturing process Commercially scaled Cost effective, reusable devices Healthcare Provider Benefits Consistent, reliable delivery Preferred by...

October 28, 2025

Privacy Policy


Privacy This site and all of the contents therein are the exclusive property of PharmaJet, Inc. The purpose of this site is to provide information about PharmaJet, our mission, our products, and our future plans. We reserve the right to alter, change or delete any material from these pages at any time, and without notice....

October 5, 2021

India’s DNA COVID vaccine is a world first – more are coming


The ZyCoV-D vaccine heralds a wave of DNA vaccines for various diseases that are undergoing clinical trials around the world.

Nature

Tags: , , ,

September 9, 2021

PharmaJet selected to deliver Scancell COVID-19 DNA Vaccine


GOLDEN, Colo. — September 14, 2021 – PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner, Scancell, has selected its devices to administer its two SARS-CoV-2 DNA vaccine candidates, SCOV1 and SCOV2. The vaccines will be exclusively administered using the PharmaJet Tropis® and PharmaJet Stratis® Needle-free Injection Systems.

Tags: , , , , ,

In the pipeline: What the next wave of COVID-19 vaccines could look like


We take a look at some of the COVID-19 vaccine candidates moving through clinical trials.

BioPharma-Reporter.com

Tags: , , ,

September 1, 2021

Indian Government Authorizes Needle-Free Covid Vaccine


On Friday, the Indian government authorized a needle-free Covid-19 vaccine developed by an indigenous pharmaceutical company.

Forbes

Tags: , , ,

August 26, 2021

PharmaJet partner Zydus Cadila announces Emergency Use Authorization approval for world’s first plasmid DNA COVID-19 vaccine


GOLDEN, Colo. — August 23, 2021 – PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner, Zydus Cadila has received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D the world’s first Plasmid DNA Vaccine for COVID-19. The vaccine, ZyCoV-D, is exclusively administered using the PharmaJet Tropis® Needle-free Injection System.

Tags: , , ,

August 23, 2021

Covid-19:Decision On Zydus Cadila Zyov-D Approval Expected Soon, Says Dr VK Paul


New Delhi: A decision on the approval of Zydus Cadila’s COVID-19 vaccine Zydus Cov-D is expected soon…

Medical Dialogue

Tags: ,

July 13, 2021

Zydus Cadila plans to roll out COVID vaccine 45-60 days after EUA nod; key points on needle-free, plasmid DNA shot


ZyCov-D when approved will help not only adults but also adolescents in the 12 to 18 years age group

Firstpost

Tags: , , ,

PharmaJet partner Zydus Cadila seeks EUA on world’s first plasmid DNA COVID-19 vaccine


GOLDEN, Colo. — July 7, 2021 – PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner Zydus Cadila has applied for Emergency Use Authorization (EUA) to the office of the Drug Controller General of India (DCGI) for its plasmid DNA Vaccine against COVID-19. The vaccine, ZyCoV-D, will be exclusively administered using the PharmaJet Tropis® Needle-free Injection System. Zydus Cadila is a global pharmaceutical company based in India, that develops, manufactures, and markets a broad range of healthcare therapies, including small molecule drugs, biologic therapeutics, and vaccines.

Tags: , , ,

July 2, 2021

COVID-19 DNA vaccine trial commences Down Under


Researchers are set to commence the first Phase 1 human trial …

Lab and Life Scientist

Tags: , , ,

July 1, 2021

Astonishing New Trials For A Needle-Free Covid Vaccine


The trial of a needle-free covid vaccine is now being tested on volunteers throughout Australia.

Triple M

Tags: , , ,

Update: PharmaJet Needle-free COVID-19 Vaccine Trial


GOLDEN, Colo. — June 30, 2021 — PharmaJet®, the maker of innovative, needle-free injection technology, today announced that patient enrollment has started for the phase 1 trial in Australia using its Needle-free Injection Systems to deliver a vaccine against SARS-CoV-2. COVIGEN, a DNA-based vaccine was developed by French-Thai pharmaceutical company BioNet-Asia in collaboration with and Melbourne-based biotech Technovalia. The PharmaJet System was chosen due to its record of increasing the effectiveness of DNA vaccines, ease-of-use, and speed of the delivery system compared to traditional needle and syringe.

Tags: , , , , ,

June 28, 2021

The Lancet Publication Confirms Viability of Intradermal Polio Vaccination


GOLDEN, Colo. — June 3, 2021– A systematic review and meta-analysis published in the April 30, 2021 issue of The Lancet strengthens evidence from previous publications that fractional dose delivery is a viable alternative to full dose inactivated polio vaccine (IPV). Previous studies have shown that two doses of intradermally-delivered IPV (60% less vaccine) were more immunogenic than one full dose delivered intramuscularly. Intradermal fractional dose delivery also lowers the total cost of vaccination substantially.

Tags: ,

May 31, 2021

Global NGO expands use of PharmaJet for Polio Eradication Campaigns


GOLDEN, Colo. — March 9, 2021 — PharmaJet ® , the maker of innovative, needle-free injection technology, today announced that a global NGO (Non-governmental organization) has expanded the use of its Tropis® Needle-free Injection System in polio eradication campaigns. The latest country addition, Somalia, adds to the already successful vaccination programs in Pakistan, Cuba, The Gambia and others.

Tags: ,

March 5, 2021

Page 8 of 12